4//SEC Filing
ADAMS ERIC A 4
Accession 0001213900-23-018866
CIK 0001728328other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 3:43 PM ET
Size
5.3 KB
Accession
0001213900-23-018866
Insider Transaction Report
Form 4
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
- Expiration (Short)
Employee Stock Option (Expiration)
2023-03-08−545→ 27,957 totalExercise: $927.64From: 2018-03-08Exp: 2023-03-08→ Common shares (545 underlying)
Footnotes (1)
- [F1]Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001817882
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 3:43 PM ET
- Size
- 5.3 KB